GV joins $50 million round in Rome Therapeutics to research ‘junk DNA’ for cancer therapies

Rome Therapeutics, which is using ML to explore the human genome and develop new treatments for cancer, has launched with $50 million in funding.Read More

via VentureBeat

Check out the Finding Your Identity Podcast!